UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Nuclear lamins

Cold Spring Harbor perspectives in biology, 2010-11, Vol.2 (11), p.a000547-a000547

2010

Volltextzugriff (PDF)

Lectin-nanoparticle concept for free PSA glycovariant providing superior cancer specificity

Clinica chimica acta, 2024-06, Vol.559, p.119689-119689, Article 119689

2024

Volltextzugriff (PDF)

Prediction of neo-adjuvant chemotherapy response in bladder cancer: the impact of clinical parameters and routine biomarkers

Scandinavian journal of urology, 2021-11, Vol.55 (6), p.448-454

2021

Volltextzugriff (PDF)

Gut microbiota signatures associate with prostate cancer risk

European urology open science (Online), 2022-08, Vol.42, p.S36

2022

Volltextzugriff (PDF)

225: Patient-derived tissue culture and xenograft models for studying prostate tumor responses to therapy

European journal of cancer (1990), 2014-07, Vol.50, p.S52-S52

2014

Volltextzugriff (PDF)

Transurethral ultrasound therapy for benign prostatic obstruction in humans

European urology open science (Online), 2020-07, Vol.19, p.e997

2020

Volltextzugriff (PDF)

Early experience of salvage MRI guided transurethral ultrasound ablation for local prostate cancer recurrence after radiotherapy

European urology open science (Online), 2020-07, Vol.19, p.e1408

2020

Volltextzugriff (PDF)

A0965 - Salvage Transurethral Ultrasound Ablation (TULSA) for localized radio-recurrent prostate cancer: 12-month safety and oncological outcomes

European urology, 2023-02, Vol.83, p.S1383-S1383

2023

Volltextzugriff (PDF)

Salvage Transurethral Ultrasound Ablation (TULSA) for localized radio-recurrent prostate cancer: 12-month safety and oncological outcomes

European urology, 2023-02, Vol.83, p.S1383

2023

Volltextzugriff (PDF)

Mutant p53-associated myosin-X upregulation promotes breast cancer invasion and metastasis

The Journal of clinical investigation, 2014-03, Vol.124 (3), p.1069-1082

2014

Volltextzugriff (PDF)

A0694 - MRI-guided transurethral ultrasound ablation (TULSA) for the treatment of benign prostatic hyperplasia: 12-month outcomes of a phase 1-2 study

European urology, 2024-03, Vol.85, p.S1651-S1651

2024

Volltextzugriff (PDF)

MRI-guided transurethral ultrasound ablation (TULSA) for the treatment of benign prostatic hyperplasia: 12-month outcomes of a phase 1-2 study

European urology, 2024-03, Vol.85, p.S1651

2024

Volltextzugriff (PDF)

Safety, efficacy and quality of life outcomes of MRI-guided transurethral ultrasound ablation for localized prostate cancer: 12-month outcomes

European urology, 2024-03, Vol.85, p.S1631

2024

Volltextzugriff (PDF)

A0678 - Safety, efficacy and quality of life outcomes of MRI-guided transurethral ultrasound ablation for localized prostate cancer: 12-month outcomes

European urology, 2024-03, Vol.85, p.S1631-S1631

2024

Volltextzugriff (PDF)

Transurethral ultrasound ablation (TULSA) for benign prostatic hyperplasia: Three-month clinical outcomes

European urology, 2022-02, Vol.81, p.S1085

2022

Volltextzugriff (PDF)

MRI-guided transurethral ultrasound ablation for localized clinically significant prostate cancer: 12-month clinical outcomes of a phase 2 study

European urology, 2022-02, Vol.81, p.S488

2022

Volltextzugriff (PDF)

A0966 - 12-month clinical outcomes of MRI-guided transurethral ultrasound ablation for localized prostate cancer

European urology, 2023-02, Vol.83, p.S1384-S1384

2023

Volltextzugriff (PDF)

12-month clinical outcomes of MRI-guided transurethral ultrasound ablation for localized prostate cancer

European urology, 2023-02, Vol.83, p.S1384

2023

Volltextzugriff (PDF)

12 months clinical outcomes of Transurethral UltraSound Ablation (TULSA) for benign prostatic hyperplasia

European urology, 2023-02, Vol.83, p.S340

2023

Volltextzugriff (PDF)

A0241 - 12 months clinical outcomes of Transurethral UltraSound Ablation (TULSA) for benign prostatic hyperplasia

European urology, 2023-02, Vol.83, p.S340-S340

2023

Volltextzugriff (PDF)

MRI-guided transurethral ultrasound ablation for treatment of benign prostatic obstruction

European urology, 2021-06, Vol.79, p.S71

2021

Volltextzugriff (PDF)

Predicting the Need for Biopsy to Detect Clinically Significant Prostate Cancer in Patients with a Magnetic Resonance Imaging–detected Prostate Imaging Reporting and Data System/Likert ≥3 Lesion: Development and Multinational External Validation of the Imperial Rapid Access to Prostate Imaging and Diagnosis Risk Score

European urology, 2022-11, Vol.82 (5), p.559-568

2022

Volltextzugriff (PDF)

Accurate Prostate Cancer Detection and Segmentation Using Non-Local Mask R-CNN With Histopathological Ground Truth

International journal of radiation oncology, biology, physics, 2021-11, Vol.111 (3), p.S45-S45

2021

Volltextzugriff (PDF)

ANO7 is associated with aggressive prostate cancer

International journal of cancer, 2018-11, Vol.143 (10), p.2479-2487

2018

Volltextzugriff (PDF)

1 – 25 von 63

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(59)

Publikationsform

Artikel
(63)

Sprache

Englisch
(63)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Nuclear lamins

Lectin-nanoparticle concept for free PSA glycovariant providing superior cancer specificity

Prediction of neo-adjuvant chemotherapy response in bladder cancer: the impact of clinical parameters and routine biomarkers

Gut microbiota signatures associate with prostate cancer risk

225: Patient-derived tissue culture and xenograft models for studying prostate tumor responses to therapy

Transurethral ultrasound therapy for benign prostatic obstruction in humans

Early experience of salvage MRI guided transurethral ultrasound ablation for local prostate cancer recurrence after radiotherapy

A0965 - Salvage Transurethral Ultrasound Ablation (TULSA) for localized radio-recurrent prostate cancer: 12-month safety and oncological outcomes

Salvage Transurethral Ultrasound Ablation (TULSA) for localized radio-recurrent prostate cancer: 12-month safety and oncological outcomes

Mutant p53-associated myosin-X upregulation promotes breast cancer invasion and metastasis

A0694 - MRI-guided transurethral ultrasound ablation (TULSA) for the treatment of benign prostatic hyperplasia: 12-month outcomes of a phase 1-2 study

MRI-guided transurethral ultrasound ablation (TULSA) for the treatment of benign prostatic hyperplasia: 12-month outcomes of a phase 1-2 study

Safety, efficacy and quality of life outcomes of MRI-guided transurethral ultrasound ablation for localized prostate cancer: 12-month outcomes

A0678 - Safety, efficacy and quality of life outcomes of MRI-guided transurethral ultrasound ablation for localized prostate cancer: 12-month outcomes

Transurethral ultrasound ablation (TULSA) for benign prostatic hyperplasia: Three-month clinical outcomes

MRI-guided transurethral ultrasound ablation for localized clinically significant prostate cancer: 12-month clinical outcomes of a phase 2 study

A0966 - 12-month clinical outcomes of MRI-guided transurethral ultrasound ablation for localized prostate cancer

12-month clinical outcomes of MRI-guided transurethral ultrasound ablation for localized prostate cancer

12 months clinical outcomes of Transurethral UltraSound Ablation (TULSA) for benign prostatic hyperplasia

A0241 - 12 months clinical outcomes of Transurethral UltraSound Ablation (TULSA) for benign prostatic hyperplasia

MRI-guided transurethral ultrasound ablation for treatment of benign prostatic obstruction

Accurate Prostate Cancer Detection and Segmentation Using Non-Local Mask R-CNN With Histopathological Ground Truth

ANO7 is associated with aggressive prostate cancer

Combined Use of Prostate-specific Antigen Density and Magnetic Resonance Imaging for Prostate Biopsy Decision Planning: A Retrospective Multi-institutional Study Using the Prostate Magnetic Resonance Imaging Outcome Database (PROMOD)

Suchergebnisse filtern